289 related articles for article (PubMed ID: 37341991)
1. Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes.
Lei PJ; Pereira ER; Andersson P; Amoozgar Z; Van Wijnbergen JW; O'Melia MJ; Zhou H; Chatterjee S; Ho WW; Posada JM; Kumar AS; Morita S; Menzel L; Chung C; Ergin I; Jones D; Huang P; Beyaz S; Padera TP
J Exp Med; 2023 Sep; 220(9):. PubMed ID: 37341991
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes.
Li YL; Chen CH; Chen JY; Lai YS; Wang SC; Jiang SS; Hung WC
Oncoimmunology; 2020 Oct; 9(1):1830513. PubMed ID: 33117603
[TBL] [Abstract][Full Text] [Related]
3. MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions.
Gkountidi AO; Garnier L; Dubrot J; Angelillo J; Harlé G; Brighouse D; Wrobel LJ; Pick R; Scheiermann C; Swartz MA; Hugues S
Cancer Immunol Res; 2021 Jul; 9(7):748-764. PubMed ID: 33952631
[TBL] [Abstract][Full Text] [Related]
4. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
5. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
Huang SC; Wei PC; Hwang-Verslues WW; Kuo WH; Jeng YM; Hu CM; Shew JY; Huang CS; Chang KJ; Lee EY; Lee WH
EMBO Mol Med; 2017 Dec; 9(12):1660-1680. PubMed ID: 28993429
[TBL] [Abstract][Full Text] [Related]
7. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.
Núñez NG; Tosello Boari J; Ramos RN; Richer W; Cagnard N; Anderfuhren CD; Niborski LL; Bigot J; Meseure D; De La Rochere P; Milder M; Viel S; Loirat D; Pérol L; Vincent-Salomon A; Sastre-Garau X; Burkhard B; Sedlik C; Lantz O; Amigorena S; Piaggio E
Nat Commun; 2020 Jun; 11(1):3272. PubMed ID: 32601304
[TBL] [Abstract][Full Text] [Related]
8. Lymph Node Stromal Cell-Intrinsic MHC Class II Expression Promotes MHC Class I-Restricted CD8 T Cell Lineage Conversion to Regulatory CD4 T Cells.
Honan AM; Vazquez EN; Chen Z
J Immunol; 2021 Sep; 207(6):1530-1544. PubMed ID: 34408011
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8
Li X; Zhai J; Shen Y; Zhang T; Wang Y; He Y; You Q; Shen L
Cancer Immunol Immunother; 2022 Dec; 71(12):3057-3070. PubMed ID: 35633411
[TBL] [Abstract][Full Text] [Related]
10. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation.
Giatromanolaki A; Koukourakis IM; Chatzipantelis P; Kouroupi M; Balaska K; Koukourakis MI
Immunol Res; 2020 Dec; 68(6):363-372. PubMed ID: 33150567
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40.
Ramstad T; Lawnicki L; Vetto J; Weinberg A
Am J Surg; 2000 May; 179(5):400-6. PubMed ID: 10930490
[TBL] [Abstract][Full Text] [Related]
13. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.
Zuckerman NS; Yu H; Simons DL; Bhattacharya N; Carcamo-Cavazos V; Yan N; Dirbas FM; Johnson DL; Schwartz EJ; Lee PP
Int J Cancer; 2013 Jun; 132(11):2537-47. PubMed ID: 23136075
[TBL] [Abstract][Full Text] [Related]
14. Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients.
Chang AY; Bhattacharya N; Mu J; Setiadi AF; Carcamo-Cavazos V; Lee GH; Simons DL; Yadegarynia S; Hemati K; Kapelner A; Ming Z; Krag DN; Schwartz EJ; Chen DZ; Lee PP
J Transl Med; 2013 Oct; 11():242. PubMed ID: 24088396
[TBL] [Abstract][Full Text] [Related]
15. Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients.
Mehdipour F; Razmkhah M; Hosseini A; Bagheri M; Safaei A; Talei AR; Ghaderi A
Scand J Immunol; 2016 Mar; 83(3):195-202. PubMed ID: 26708831
[TBL] [Abstract][Full Text] [Related]
16. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.
Kohrt HE; Nouri N; Nowels K; Johnson D; Holmes S; Lee PP
PLoS Med; 2005 Sep; 2(9):e284. PubMed ID: 16124834
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
18. Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses.
Kish DD; Gorbachev AV; Fairchild RL
J Leukoc Biol; 2007 Jul; 82(1):85-92. PubMed ID: 17412917
[TBL] [Abstract][Full Text] [Related]
19. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
20. Memory CD4
Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
